Neuralgia clinical trials

Explore recruiting neuralgia clinical trials.

Recruiting neuralgia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neuralgia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II/III, multicentre, 8-week run-in phase followed by a 12- week, prospective, parallel-group, double-blind, randomized withdrawal, placebo-controlled study, with a 52 week open label extension, to evaluate the efficacy and safety of daily 1.5 to 3.5 mg basimglurant in patients with pain associated with trigeminal neuralgia with suboptimal response to their current anti-pain therapy

Italy, Germany, Denmark, Poland, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Safety and efficacy of botulinum toxin A in patients with trigeminal neuralgia: a double-blind, randomized, placebo-controlled, parallel-group trial and investigation of neuro-inflammatory biomarkers as predictors of efficacy

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-Finding Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of iN1011-N17-02 in Patients with Post herpetic Neuralgia (PHN)

Poland, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

APICALE - Cervical facet injection of corticosteroids for the management of cervicobrachialgia : protocol for a randomized pilot study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double-blind, randomized 2 arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate or severe chronic neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Germany, Bulgaria, Spain, Hungary, France, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety and immunogenicity of Shingrix vaccination in patients suffering from Psoriasis or Psoriatic arthritis

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Neuralgia trials by city

Neuralgia in Toronto Neuralgia in Vancouver Neuralgia in Montreal Neuralgia in Calgary Neuralgia in Edmonton Neuralgia in Ottawa Neuralgia in Winnipeg Neuralgia in Quebec City Neuralgia in Hamilton Neuralgia in Kitchener Neuralgia in London Neuralgia in Halifax Neuralgia in New York Neuralgia in Los Angeles Neuralgia in Chicago Neuralgia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease